These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 502748)

  • 1. Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Life Sci; 1979 Jun; 24(24):2279-84. PubMed ID: 502748
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Pharmacol Res Commun; 1980 Jul; 12(7):683-8. PubMed ID: 7403237
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute and subacute effects of haloperidol on dopac levels in the substantia nigra and ventral tegmental area of rat brain.
    Scatton B
    Eur J Pharmacol; 1979 Jun; 56(1-2):183-4. PubMed ID: 467510
    [No Abstract]   [Full Text] [Related]  

  • 5. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E; Friedhoff AJ; Friedman E
    Life Sci; 1980 Feb; 26(7):541-7. PubMed ID: 7366335
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
    Wuerthele SM; Friedle NM; Moore KE
    J Neural Transm; 1979; 45(2):117-27. PubMed ID: 469523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration.
    Cottingham SL; Pickar D; Shimotake TK; Montpied P; Paul SM; Crawley JN
    Cell Mol Neurobiol; 1990 Mar; 10(1):41-50. PubMed ID: 1970757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat.
    Levinson AJ; Garside S; Rosebush PI; Mazurek MF
    Neuroscience; 1998 May; 84(1):201-11. PubMed ID: 9522374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra.
    Deutch AY; Tam SY; Roth RH
    Brain Res; 1985 Apr; 333(1):143-6. PubMed ID: 3995282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine release in substantia nigra?
    Korf J; Zieleman M; Westerink BH
    Nature; 1976 Mar; 260(5548):257-8. PubMed ID: 1256566
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of acute and chronic ethanol on dopamine synthesis in the caudate nucleus, substantia nigra and frontal cortex.
    Fadda F; Argiolas A; Melis MR; Serra G
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2553-8. PubMed ID: 7470302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phencyclidine suppresses the activity of midbrain dopamine-containing neurons recorded from mouse brain slices in vitro.
    Trulson ME; Arasteh K
    Eur J Pharmacol; 1987 Jan; 133(3):345-9. PubMed ID: 3556396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
    Teicher MH; Barber NI; Gelbard HA; Gallitano AL; Campbell A; Marsh E; Baldessarini RJ
    Neuropsychopharmacology; 1993 Sep; 9(2):147-56. PubMed ID: 8216697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.